# US 2013/0253087 A1 · Hydrogel filaments for biomedical uses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0253087 A1
- Document ID: US20130253087A1
- Status: Published application
- Kind: A1
- Application number: 13/899,357
- Filed: 2013-05-21
- Published: 2013-09-26
- Earliest claimed: 2007-12-21
- Assignees: MicroVention, Inc.
- Applicants: MicroVention, Inc.
- Inventors: Gregory M. Cruise; Michael J. Constant; Edward Michael Keeley; Terrance T. Tran
- Web page: https://patentgrep.com/patent/US20130253087A1

## CPC

- A61B 17/12113: {within an aneurysm}
- A61B 17/12181: {formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices}
- A61B 90/39: {Markers, e.g. radio-opaque or breast lesions markers}
- A61K 49/0404: {containing barium sulfate}
- A61L 24/001: {Use of materials characterised by their function or physical properties}
- A61L 24/0031: {Hydrogels or hydrocolloids}
- A61L 24/046: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence)}
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 31/048: {obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence)}
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 31/18: Materials at least partially X-ray or laser opaque
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/1205: {Introduction devices}
- A61B 2090/3966: {Radiopaque markers visible in an X-ray image}
- A61L 2430/36: for embolization or occlusion, e.g. vaso-occlusive compositions or devices
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Described herein are apparatus, compositions, systems and associated methods to occlude structures and malformations with radiopaque hydrogel filaments with delayed controlled rates of expansion permitting the repositioning of the device once inside the structure or malformation. Further described is a device for implantation in an animal comprising a difunctional, low molecular weight ethylenically unsaturated shapeable macromer; an ethylenically unsaturated monomer; and a radiopaque element, wherein said device contains no support members. Methods of forming such devices are also disclosed.

## Claims

### Claim 1

A method for preparing a device for implantation comprising:
combining a difunctional, low molecular weight ethylenically unsaturated macromer, an ethylenically unsaturated monomer, a visualization agent, and a solvent to prepare a prepolymer solution; and
preparing a hydrogel from the prepolymer solution,
wherein the device has no support members.

### Claim 2 (depends on 1)

The method according to claim 1 wherein said solvent comprises water, dichloromethane, acetone, isopropyl alcohol, ethanol or combinations thereof.

### Claim 3 (depends on 1)

The method according to claim 1 wherein said solvent comprises about 20% w/w to about 80% w/w of the prepolymer solution.

### Claim 4 (depends on 1)

The method according to claim 1 wherein said difunctional, low molecular weight ethylenically unsaturated macromer has a molecular weight of about 100 grams/mole to about 5000 grams/mole.

### Claim 5 (depends on 1)

The method according to claim 1 wherein said difunctional, low molecular weight ethylenically unsaturated macromer comprises polyethylene glycol, propylene glycol, poly(tetramethylene oxide), poly(ethylene glycol)diacrylamide, poly(ethylene glycol)diacrylate, poly(ethylene glycol)dimethacrylate, derivatives thereof, or combinations thereof.

### Claim 6 (depends on 1)

The method according to claim 1 wherein said ethylenically unsaturated monomer comprises one or more ionizable functional groups.

### Claim 7 (depends on 6)

Them method according to claim 6, further comprising treating said hydrogel to render the hydrogel expansible at physiological conditions.

### Claim 8 (depends on 7)

The method according to claim 7 wherein said ionizable functional groups comprise basic groups and said treating step comprises de-protonating said basic groups at pHs greater than the pKa or protonating said basic groups at pHs less than the pKa of said basic groups.

### Claim 9 (depends on 7)

The method according to claim 7 wherein said ionizable functional groups comprise acidic groups and said treating step comprises protonating said acidic groups at pHs less than the pKa or de-protonating said acidic groups at pHs greater than the pKa of said acidic groups.

### Claim 10 (depends on 1)

The method according to claim 1 wherein said ethylenically unsaturated monomer comprises about 40% to about 80% by weight of the prepolymer solution.

### Claim 11 (depends on 1)

The method according to claim 1 wherein said ethylenically unsaturated monomer comprises N,N′-methylenebisacrylamide, N-vinyl pyrrolidinone, 2-hydroxyethyl methacrylate, derivatives thereof, or combinations thereof.

### Claim 12 (depends on 1)

The method according to claim 1 wherein said visualization agent comprises an aromatic ring having a single unsaturation point and at least one iodine atom.

### Claim 13 (depends on 1)

The method according to claim 1 wherein said visualization agent comprises gadolinium or iron oxide.

### Claim 14 (depends on 1)

The method according to claim 1 wherein said visualization element comprise 2,4,6-triiodophenyl penta-4-enoate, 5-acrylamido-2,4,6-triiodo-n,n′-bis-(2,3 dihydroxypropyl) isophthalamide, derivatives thereof, or combinations thereof.

### Claim 15 (depends on 1)

The method according to claim 1 further comprising the step of adding a second ethylenically unsaturated monomer to said prepolymer solution.

### Claim 16 (depends on 1)

The method according to claim 1 wherein said hydrogel is substantially free of acrylamide.

### Claim 17 (depends on 1)

The method according to claim 1 wherein said hydrogel is substantially non-bioresorbable.

### Claim 18 (depends on 1)

The method according to claim 1 wherein said hydrogel is bioresorbable.

### Claim 19 (depends on 1)

The method according to claim 1 wherein the hydrogel filament has a buckling force of 0.5±0.4 gf.
